At the Biotechnology Industry Organization’s (BIO) annual BIO CEO & Investor conference we heard Alexis Borisy, President & CEO of CombinatoRx (NASDAQ: CRXX), describe its high throughput screening technology for active molecule combinations....
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)